Peihua Ni

3.1k total citations · 2 hit papers
51 papers, 2.4k citations indexed

About

Peihua Ni is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Peihua Ni has authored 51 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Peihua Ni's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (5 papers). Peihua Ni is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (5 papers). Peihua Ni collaborates with scholars based in China, United States and Hong Kong. Peihua Ni's co-authors include Xiangfan Liu, Qishi Fan, Jiayi Wang, Zhidong Gu, Ning Chen, Yongxia Qiao, Huacheng Wu, Fenyong Sun, Dakang Xu and Xiangliang Yuan and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Oncogene.

In The Last Decade

Peihua Ni

51 papers receiving 2.4k citations

Hit Papers

CREB up-regulates long no... 2010 2026 2015 2020 2010 2020 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peihua Ni 1.5k 1.1k 507 443 253 51 2.4k
Keiichi Tamai 1.3k 0.8× 916 0.8× 260 0.5× 355 0.8× 421 1.7× 63 2.2k
Mihai Gagea 1.6k 1.0× 784 0.7× 363 0.7× 506 1.1× 208 0.8× 62 2.4k
Tarik Regad 1.4k 0.9× 551 0.5× 432 0.9× 538 1.2× 260 1.0× 31 2.3k
Krista La Perle 1.3k 0.9× 737 0.6× 379 0.7× 526 1.2× 237 0.9× 29 2.2k
Daekwan Seo 1.4k 0.9× 532 0.5× 343 0.7× 645 1.5× 356 1.4× 46 2.6k
Yongyu Shi 1.3k 0.8× 379 0.3× 868 1.7× 624 1.4× 358 1.4× 65 2.5k
Praveen Bhoopathi 964 0.6× 500 0.4× 403 0.8× 628 1.4× 164 0.6× 52 1.9k
Yan Teng 1.3k 0.8× 506 0.4× 269 0.5× 354 0.8× 106 0.4× 71 1.9k
Yinjing Song 1.2k 0.8× 858 0.8× 726 1.4× 314 0.7× 186 0.7× 49 2.1k

Countries citing papers authored by Peihua Ni

Since Specialization
Citations

This map shows the geographic impact of Peihua Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peihua Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peihua Ni more than expected).

Fields of papers citing papers by Peihua Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peihua Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peihua Ni. The network helps show where Peihua Ni may publish in the future.

Co-authorship network of co-authors of Peihua Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Peihua Ni. A scholar is included among the top collaborators of Peihua Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peihua Ni. Peihua Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Bo, Peihua Ni, Xiao Liang, & Wenpei Fan. (2025). Design of nanomaterials for enhanced cancer immunotherapy: A review. Nano Biomedicine and Engineering. 18(1). 100002–100002. 1 indexed citations
2.
Ying, Le, Feng Yan, Liang Yu, et al.. (2018). PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers. OncoImmunology. 7(6). e1433520–e1433520. 31 indexed citations
3.
Lin, Jiafei, Yingwei Zhang, Jiemin Wu, et al.. (2018). Neuropilin 1 (NRP1) is a novel tumor marker in hepatocellular carcinoma. Clinica Chimica Acta. 485. 158–165. 35 indexed citations
4.
Chen, Jia, Haichen Zhang, Ying Chen, et al.. (2017). miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT. Experimental Cell Research. 352(1). 104–112. 64 indexed citations
5.
Wu, Jiemin, et al.. (2016). The fourth transmembrane helix is important for DRAM function. Acta Biochimica et Biophysica Sinica. 48(3). 298–300. 1 indexed citations
6.
Liu, Xiaoyan, et al.. (2015). Association of SNPs in miR-146a, miR-196a2, and miR-499 with the risk of endometrial/ovarian cancer. Acta Biochimica et Biophysica Sinica. 47(7). 564–566. 20 indexed citations
7.
Liu, Xiangfan, Ling Yao, Zhidong Gu, et al.. (2013). Somatic mutational analysis of FAK in breast cancer: A novel gain-of-function mutation due to deletion of exon 33. Biochemical and Biophysical Research Communications. 443(2). 363–369. 19 indexed citations
8.
Ni, Peihua, Hong Xu, Huiping Xue, Bing Lin, & Yang Lu. (2012). A Meta-Analysis of Interleukin-10-1082 Promoter Polymorphism Associated with Gastric Cancer Risk. DNA and Cell Biology. 31(4). 582–591. 25 indexed citations
9.
Ni, Peihua. (2011). Relationship of cerebral infarction with paraoxonase 1 gene 192G/A polymorphism. 1 indexed citations
10.
Ni, Peihua. (2011). Correlation between NAD(P)H oxidase p22phox C242T polymorphism and cerebral infarction. Laboratory Medicine. 1 indexed citations
11.
Cui, Yun, Huiping Xue, Bing Lin, Peihua Ni, & Jing‐Yuan Fang. (2011). A Meta-Analysis of CDH1 C-160A Genetic Polymorphism and Gastric Cancer Risk. DNA and Cell Biology. 30(11). 937–945. 19 indexed citations
12.
Xue, Huiping, et al.. (2011). X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Gastric Cancer Risk: A HuGE Review and Meta-Analysis. American Journal of Epidemiology. 173(4). 363–375. 55 indexed citations
13.
Fu, Yi, Peihua Ni, Jianfang Ma, et al.. (2011). Polymorphisms of Human Vascular Endothelial Growth Factor Gene Are Associated with Acute Cerebral Infarction in the Chinese Population. European Neurology. 66(1). 47–52. 9 indexed citations
14.
Zhao, Jianxing, Hong Chen, Peihua Ni, et al.. (2011). Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection. Journal of Chromatography B. 879(26). 2720–2725. 55 indexed citations
15.
Zhao, Zhen, Huacheng Wu, Jiayi Wang, et al.. (2010). Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1‐related epidermal growth factor signaling pathway. Cancer Science. 101(6). 1454–1462. 49 indexed citations
16.
Guo, Xinfeng, Yu Pan, Peihua Ni, et al.. (2010). Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene. 29(27). 3908–3920. 74 indexed citations
17.
Wang, Jiayi, Xiangfan Liu, Huacheng Wu, et al.. (2010). CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Research. 38(16). 5366–5383. 841 indexed citations breakdown →
18.
Wang, Jiayi, Xiangfan Liu, Peihua Ni, Zhidong Gu, & Qishi Fan. (2010). SP1 is required for basal activation and chromatin accessibility of CD151 promoter in liver cancer cells. Biochemical and Biophysical Research Communications. 393(2). 291–296. 19 indexed citations
19.
Xue, Huiping, Bin Lin, Peihua Ni, Hong Xu, & Gang Huang. (2010). Interleukin‐1B and interleukin‐1 RN polymorphisms and gastric carcinoma risk: A meta‐analysis. Journal of Gastroenterology and Hepatology. 25(10). 1604–1617. 96 indexed citations
20.
Wang, Niansong, Ying Fan, Peihua Ni, et al.. (2008). High glucose effect on the role of CD146 in human proximal tubular epithelial cells in vitro. Journal of Nephrology. 21(6). 931–940. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026